Sentry Investment Management LLC Decreases Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Sentry Investment Management LLC lessened its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 16.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,423 shares of the medical equipment provider's stock after selling 488 shares during the period. Intuitive Surgical accounts for 0.6% of Sentry Investment Management LLC's investment portfolio, making the stock its 27th largest position. Sentry Investment Management LLC's holdings in Intuitive Surgical were worth $1,265,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in ISRG. Massachusetts Financial Services Co. MA purchased a new stake in Intuitive Surgical during the third quarter valued at about $558,807,000. FMR LLC raised its position in shares of Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider's stock valued at $5,389,765,000 after purchasing an additional 838,793 shares during the period. Wilmington Savings Fund Society FSB lifted its stake in shares of Intuitive Surgical by 15,322.2% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider's stock valued at $272,980,000 after buying an additional 552,058 shares in the last quarter. Strategic Financial Concepts LLC boosted its holdings in Intuitive Surgical by 50,740.8% in the 4th quarter. Strategic Financial Concepts LLC now owns 312,671 shares of the medical equipment provider's stock worth $163,202,000 after buying an additional 312,056 shares during the period. Finally, State Street Corp grew its stake in Intuitive Surgical by 1.4% in the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider's stock valued at $7,393,673,000 after buying an additional 210,363 shares in the last quarter. Institutional investors own 83.64% of the company's stock.

Insiders Place Their Bets

In related news, EVP Myriam Curet sold 408 shares of Intuitive Surgical stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the transaction, the executive vice president now owns 353 shares in the company, valued at $208,181.75. This trade represents a 53.61 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Robert Desantis sold 376 shares of the stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the sale, the executive vice president now owns 5,506 shares of the company's stock, valued at $2,967,734. This represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 6,240 shares of company stock valued at $3,529,040. 0.80% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several equities research analysts have issued reports on the company. Wells Fargo & Company increased their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a research report on Friday, January 24th. Bernstein Bank increased their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the stock an "overweight" rating in a report on Monday, January 27th. CICC Research initiated coverage on Intuitive Surgical in a research note on Monday, January 27th. They issued a "neutral" rating and a $550.00 target price for the company. Leerink Partners upped their price target on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Finally, Erste Group Bank raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Tuesday, November 19th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $613.10.

Intuitive Surgical Stock Down 2.9 %

Shares of Intuitive Surgical stock traded down $17.27 during trading on Tuesday, hitting $573.74. 2,548,276 shares of the stock traded hands, compared to its average volume of 1,739,679. The stock has a market cap of $204.35 billion, a price-to-earnings ratio of 89.51, a PEG ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The firm's fifty day moving average is $566.43 and its 200-day moving average is $526.49.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.